Dual molecular delivery of oligonucleotides and peptide containing conjugates
Disclosed herein is a method for inhibiting expression of a gene of a subject comprising administering (1) a composition comprising R-(L)a-(G)b; wherein R is an oligonucleotide selected from the group consisting of DNA, RNA, siRNA, and microRNA; L is a linker and each occurrence of L is independently selected from Table 3; G is a targeting ligand and each occurrence of G is independently selected from Table 4; each of a and b is independently 0, 1, 2, 3 or 4; and (2) a composition comprising (P)c-(L)d-(G)e; wherein P is a peptide and each occurrence of P is independently selected from Table 2; L is a linker and each occurrence of L is independently selected from Table 3; G is a targeting ligand and each occurrence of G is independently selected from Table 4; d is 0, 1, 2, 3, 4, 5 or 6; and each of c and e is independently 1, 2, 3, 4, 5 or 6. Compositions in (1) and (2) can be co-administered or sequentially administered.
Merck Sharp & Dohme Corp.
C A C C C A C C A C A
C07K A61K C12N C12N C12N A61K C12N C12N A61K C12N A61K
additional inventional inventional additional inventional inventional additional additional inventional inventional inventional
Matthew G. Rubina G. David M. Jeffrey G. Thomas J. Steven L. Rob Kathleen B. Boyoung Weimin
Stanton Parmar Tellers Aaronson Tucker Colletti Burke Calati Kim Wang